Ensemble Discovery
Link
ensemblediscovery.com
Название компании
Ensemble Discovery
Phone
617 492-69-77
Address
99 Erie Street
E-mail
info@ensembletx.com
City
Cambridge
Country
USA
Headquarters
Cambridge, MA 02139-4535
Stage of the project
Startup
Total Raised
$15,000,000
Description
Ensemble’s mission is to develop innovative small molecule therapies to transform the treatment of cancer and other serious diseases. Founded by renowned Harvard Professor David R. Liu, Ph.D. in 2004, the company is leveraging its extensive drug discovery experience and proprietary drug discovery platform, which has been validated through successful major biopharma collaborations, to transition into a product development company.
We are developing a growing pipeline of differentiated small molecule programs that expand the boundaries of traditional small molecules to drug well-validated, but challenging disease targets inside or outside cells. Our lead oncology program is focused on immune checkpoint targets, and in particular the indoleamine 2,3-dioxygenase (IDO) pathway which is implicated in a variety of cancers including those of prostate, colorectal, pancreatic, cervical, gastric, ovarian, and lung. We also have a number of other preclinical development programs in oncology and inflammatory diseases.
We are developing a growing pipeline of differentiated small molecule programs that expand the boundaries of traditional small molecules to drug well-validated, but challenging disease targets inside or outside cells. Our lead oncology program is focused on immune checkpoint targets, and in particular the indoleamine 2,3-dioxygenase (IDO) pathway which is implicated in a variety of cancers including those of prostate, colorectal, pancreatic, cervical, gastric, ovarian, and lung. We also have a number of other preclinical development programs in oncology and inflammatory diseases.